MIT researchers will lead a four-year, up to $38 million project, funded by the U.S. Advanced Research Projects Agency for Health (ARPA-H), aimed at developing a noninvasive, wearable patch that continually monitors biomarkers of heart disease and sepsis. According to the project plan, the patch, which will capture clinical-grade health information in real time, will be powered by heat from the patient's body. It could provide essential information to help clinicians diagnose heart failure and sepsis early, before the diseases have caused irreversible damage. The researchers believe the minimally invasive device could also track the progress of a patient's recovery after they are discharged from the hospital, and assist clinicians in developing more effective therapeutic approaches. Heart disease is the number one cause of death in the U.S., while sepsis kills at least 350,000 U.S. adults each year and is the leading cause of death in hospitals, according to the Centers for Disease...
learn more
